These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


238 related items for PubMed ID: 21507775

  • 1. Rapid progression of combined hepatocellular carcinoma and cholangiocarcinoma.
    Saboo SS, Krajewski KM, Jagannathan JP, O'Regan KN, Odze R, Ramaiya N, Wolpin BM.
    Cancer Imaging; 2011 Mar 31; 11(1):37-41. PubMed ID: 21507775
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Synchronous occurrence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in both lobes of the liver.
    Topaloğlu S, Sağlam K, Çalık A, Cobanoğlu Ü, Öztürk MH.
    Turk J Gastroenterol; 2014 Apr 31; 25(2):209-11. PubMed ID: 25003684
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Synchronous double primary hepatic cancer: hepatocellular carcinoma and intrahepatic cholangiocarcinoma].
    Kim JO, Jun DW, Jang K.
    Korean J Gastroenterol; 2013 Aug 25; 62(2):135-9. PubMed ID: 24133714
    [No Abstract] [Full Text] [Related]

  • 9. Yttrium-90 Radioembolization for Unresectable Combined Hepatocellular-Cholangiocarcinoma.
    Chan LS, Sze DY, Poultsides GA, Louie JD, Abdelrazek Mohammed MA, Wang DS.
    Cardiovasc Intervent Radiol; 2017 Sep 25; 40(9):1383-1391. PubMed ID: 28432387
    [Abstract] [Full Text] [Related]

  • 10. Impact of incidental/misdiagnosed intrahepatic cholangiocarcinoma and combined hepatocellular cholangiocarcinoma on the outcomes of liver transplantation: an institutional case series and literature review.
    Gupta R, Togashi J, Akamatsu N, Sakamoto Y, Kokudo N.
    Surg Today; 2017 Aug 25; 47(8):908-917. PubMed ID: 28124125
    [Abstract] [Full Text] [Related]

  • 11. Combined hepatocellular carcinoma and cholangiocarcinoma: a case report and review of the literature.
    Zhou YM, Yang JM, Wang B, Xu F, Tong Y, Li DQ.
    Hepatobiliary Pancreat Dis Int; 2007 Dec 25; 6(6):656-9. PubMed ID: 18086637
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma.
    Zuo HQ, Yan LN, Zeng Y, Yang JY, Luo HZ, Liu JW, Zhou LX.
    Hepatobiliary Pancreat Dis Int; 2007 Apr 25; 6(2):161-5. PubMed ID: 17374575
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical Characterization of HCC/CCA Mixed Cancers in a Population-based Cohort.
    Teufel A, Rodriguez I, Winzler C, Kokh D, Ebert MP, Surovtsova I, Morakis P.
    J Gastrointestin Liver Dis; 2023 Jun 22; 32(2):190-196. PubMed ID: 37345609
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.